Skip to main content
Fig. 2 | Clinical Proteomics

Fig. 2

From: The impact of ultraviolet- and infrared-based laser microdissection technology on phosphoprotein detection in the laser microdissection-reverse phase protein array workflow

Fig. 2

Phosphoprotein abundances in laser microdissected ovarian cancer tumor epithelial cells assessed by reverse-phase protein array. ERK1/2 pT202/pY204 in the UV LMD enriched Patient 1 sample is reported at complete signal saturation (150,000 RFU). The asterisk (*) indicates a significant difference (p < 0.05) in rank orders determined by a non-parametric Mann–Whitney U Test between matched ultraviolet laser microdissection (UV LMD) and infrared laser capture microdissection (IR LCM) collections

Back to article page

Clinical Proteomics

ISSN: 1559-0275